EUROLAB
iso-10993-12-sample-preparation-and-reference-materials
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ISO 10993-12 Sample Preparation and Reference Materials Laboratory Testing Service: A Comprehensive Guide

ISO 10993-12 is a standard that outlines the requirements for sample preparation and reference materials used in biological evaluation of medical devices. The standard is published by the International Organization for Standardization (ISO) and is widely adopted across the globe.

Legal and Regulatory Framework

The legal and regulatory framework surrounding ISO 10993-12 testing is governed by various national and international standards, including:

  • EU Medical Device Regulation (EU MDR)

  • US FDA 21 CFR Part 11

  • IEC 60601-1

    • These regulations require medical device manufacturers to demonstrate the safety of their products through a risk management approach. ISO 10993-12 testing is an essential component of this process, as it provides critical data on the biological compatibility of materials used in medical devices.

    International and National Standards

    The following standards apply to ISO 10993-12 testing:

  • ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing

  • ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity

  • ISO 10993-11:2006 Biological evaluation of medical devices Part 11: Tests for systemic toxicity

    • These standards outline the requirements for sample preparation, reference materials, and testing procedures.

    Standard Development Organizations

    The following organizations play a critical role in developing and maintaining ISO 10993-12:

  • International Organization for Standardization (ISO)

  • European Committee for Standardization (CEN)

  • American Society for Testing and Materials (ASTM)

    • These organizations collaborate to develop and publish standards that ensure consistency and comparability across different regions.

    Standard Evolution and Updates

    Standards evolve over time as new technologies and research emerge. ISO 10993-12 is no exception, with regular updates to reflect changing regulatory requirements and scientific understanding.

  • ISO 10993-12:2012 Biological evaluation of medical devices Part 12: Sample preparation and reference materials

  • ISO 10993-12:2020 Biological evaluation of medical devices Part 12: Sample preparation and reference materials

    • Manufacturers must stay up-to-date with the latest standards to ensure compliance.

    Compliance Requirements for Different Industries

    Compliance with ISO 10993-12 is mandatory for manufacturers of:

  • Medical devices (EU MDR)

  • In-vitro diagnostic medical devices (IVDD Regulation)

  • Combination products (21 CFR Part 4)

    • Failure to comply can result in regulatory action, product recalls, and damage to reputation.

    ISO 10993-12 testing is essential for ensuring the safety and efficacy of medical devices. The standard provides a framework for evaluating biological responses to materials used in these products.

    Business and Technical Reasons

    The business and technical reasons for conducting ISO 10993-12 testing include:

  • Ensuring regulatory compliance

  • Protecting patient safety

  • Maintaining product quality

  • Enhancing market competitiveness

    • Manufacturers must demonstrate the safety of their products through rigorous testing, including ISO 10993-12.

    Consequences of Not Performing This Test

    Failure to perform ISO 10993-12 testing can lead to:

  • Regulatory non-compliance

  • Product recalls

  • Damage to reputation and brand value

  • Financial losses due to regulatory action

    • Manufacturers must prioritize this testing to avoid these consequences.

    Industries and Sectors Requiring This Testing

    The following industries require ISO 10993-12 testing:

  • Medical devices (EU MDR)

  • In-vitro diagnostic medical devices (IVDD Regulation)

  • Combination products (21 CFR Part 4)

    • These sectors must demonstrate the safety of their products through rigorous testing.

    Risk Factors and Safety Implications

    Biological evaluation is critical to ensuring patient safety. ISO 10993-12 testing helps manufacturers identify potential risks associated with materials used in medical devices.

    Quality Assurance and Quality Control Aspects

    Manufacturers must ensure that their quality management systems (QMS) include:

  • Standardized procedures for sample preparation

  • Reference material validation

  • Testing protocols

    • A robust QMS is essential for ensuring compliance with regulatory requirements.

    ISO 10993-12 testing involves a series of complex procedures, including:

  • Sample preparation

  • Reference material validation

  • Testing protocols

    • The following equipment and instruments are used in this process:

  • Centrifuges

  • Microscopes

  • Spectrophotometers

    • Manufacturers must follow strict protocols to ensure accurate results.

    Sample Preparation Procedures

    Sample preparation involves the collection and processing of biological materials for testing. This includes:

  • Tissue sampling

  • Cell culture preparation

  • Extract preparation

    • These procedures are critical to ensuring accurate test results.

    Testing Parameters and Conditions

    The following parameters and conditions are essential for ISO 10993-12 testing:

  • Temperature control

  • pH control

  • Sterilization protocols

    • Manufacturers must ensure that their testing protocols meet these requirements.

    Test Results and Reporting

    Test results must be documented and reported in accordance with regulatory requirements. Manufacturers must provide clear, concise reports on test findings, including any adverse effects observed.

    Conclusion

    ISO 10993-12 is a critical standard for ensuring the safety of medical devices. Manufacturers must prioritize this testing to ensure compliance with regulatory requirements. Failure to comply can result in severe consequences, including product recalls and damage to reputation.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers